Table 1.
Total N = 298 |
Very Poor Group N = 19 |
Poor Group N = 24 |
Fair Group N = 113 |
Good Group N = 142 |
p-Value | |
---|---|---|---|---|---|---|
Age Mean (SD) Gender, n (%) Male Female Education, n (%) (1 missing) Compulsory Secondary College or university Comorbidity, CCI Mean (SD) Number of daily medications Mean (SD) Geriatric depression scale ≥5, n (%) No Yes |
73.6 (6.3) 157 (52.7) 141 (47.3) 90 (30.3) 120 (40.4) 87 (29.3) 1.1 (1.3) 5.4 (3.6) 236 (79.2) 62 (20.8) |
77.7 (7.6) 12 (63.2) 7 (36.8) 6 (33.3) 11 (61.1) 1 (5.6) 1.5 (1.4) 8.7 (4.4) 12 (63.2) 7 (36.8) |
76.3 (6.4) 9 (37.5) 15 (62.5) 17 (70.8) 5 (20.8) 2 (8.3) 1.4 (1.5) 7.2 (4.0) 17 (70.8) 7 (29.2) |
74.7 (6.4) 73 (64.6) 40 (35.4) 42 (38.2) 44 (40.0) 24 (21.8) 1.3 (1.6) 5.7 (3.7) 88 (77.9) 25 (22.1) |
71.8 (5.5) 63 (44.4) 79 (55.6) 25 (17.6) 58 (40.8) 59 (41.5) 0.8 (1.0) 4.5 (2.9) 119 (83.8) 23 (16.2) |
<0.001 2 0.004 1 <0.001 1 0.003 2 <0.001 2 0.115 1 |
Number of physical impairments Mean (SD) (3 missing) Fatigue Mean (SD) (3 missing) RT treatment intent, n (%) Curative Palliative Previous cancer treatment, n (%) Endocrine therapy Other systematic cancer therapy Cancer surgery/RT Brain cancer/brain metastases, n (%) No Yes |
1.3 (1.4) 37.4 (25.3) 162 (54.4) 136 (45.6) 57 (19.1) 90 (30.2) 182 (61.1) 282 (94.6) 16 (5.4) |
3.2 (1.6) 3 45.1 (24.3) 3 (15.8) 16 (84.2) 1 (5.3) 8 (42.1) 10 (52.6) 16 (84.2) 3 (15.8) |
1.9 (1.8) 38.9 (27.6) 13 (54.2) 11 (45.8) 7 (29.2) 5 (20.8) 16 (66.7) 22 (91.7) 2 (8.3) |
1.5 (1.5) 4 38.2 (26.7) 47 (41.6) 66 (58.4) 27 (23.9) 33 (29.2) 60 (53.1) 108 (95.6) 5 (4.4) |
0.8 (0.9) 35.5 (23.9) 99 (69.7) 43 (30.3) 22 (15.5) 44 (31.0) 96 (67.6) 136 (95.8) 6 (4.2) |
<0.001 2 0.449 2 <0.001 1 0.079 1 0.499 1 0.091 1 0.169 1 |
Abbreviations: CCI, Charlson Comorbidity Index; ECOG PS, Eastern Cooperative Group performance status; Gy, Grey; p-value represents comparison of four groups, and p-values marked with bold indicate statistically significant differences. 1 χ2-test, 2 ANOVA, 3 One missing, 4 Two missing.